Announced
Completed
SK Biopharmaceuticals completed the acquisition of Shinoken Group for $371m.
Synopsis
SK Biopharmaceuticals, a pharmaceutical company, completed the acquisition of Shinoken Group, a Japanese professional services and investment management holding company, for $371m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (1)
Bidder Team (4)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite